Concepedia

Ilaria Depetris

ID

Statistics

Publications

10

Citations

1.5K

H-Index

10

Active since

2016

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Candiolo Cancer Institute

University of Turin

Istituto Oncologico Veneto

University of Modena and Reggio Emilia

Ilaria Depetris is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2016–2023

10

Publications

10

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

Andrea Sartore‐Bianchi, Livio Trusolino, Cosimo Martino et al. · The Lancet Oncology · 2016 · 1K citations · Full text

, , +14

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

Fotios Loupakis, Ilaria Depetris, Paola Biason et al. · The Oncologist · 2020 · 112 citations · Full text

, , +17

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 84 citations · Full text

, , +17

A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

Fotios Loupakis, Rossana Intini, Chiara Cremolini et al. · European Journal of Cancer · 2019 · 70 citations · Full text

, , +16

The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer

Massimiliano Salati, Roberto Filippi, Caterina Vivaldi et al. · Liver International · 2019 · 59 citations · Full text

, , +17

1–5 of 10